#11 - Healthcare Fragmentation and Survival in Patients With Hepatocellular Carcinoma: a Nationwide Population-based Cohort Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction and Objectives Healthcare fragmentation may affect cancer outcomes by disrupting continuity of care, delaying treatment coordination, and limiting multidisciplinary management. Its association with survival in hepatocellular carcinoma (HCC) remains insufficiently characterized in Latin American health systems. To evaluate the association between healthcare fragmentation and 3-year overall survival among adults with incident HCC in Colombia. Materials and Methods Nationwide retrospective population-based cohort study using linked Colombian administrative health databases from 2011 to 2022. Adults aged 18 years with incident HCC diagnosed between 2011 and 2019 were included. HCC was identified through a hierarchical algorithm using ICD-10 codes, HCC-specific treatments, liver-directed procedures, and imaging records. Healthcare fragmentation was defined as care from 2 independent providers during a 90-day landmark period after diagnosis. Three-year overall survival was estimated from the end of this period. Propensity score matching was performed, and survival was analyzed using a parametric Weibull model. Results Among 5,457 eligible patients with incident HCC, 3,287 (60.2%) experienced fragmented care and 2,170 (39.8%) received non-fragmented care. After 1:1 propensity score matching, the final cohort included 4,126 patients. Non-fragmented care was associated with lower all-cause mortality compared with fragmented care (HR 0.72, 95% CI 0.66–0.79; p<0.001). Mortality was higher in the fragmented group at 12 months (39.8% vs 28.1%) and 36 months (61.1% vs 51.2%). Conclusions In this nationwide Colombian cohort, healthcare fragmentation was associated with worse 3-year overall survival among patients with HCC. These findings support the need for integrated care pathways and multidisciplinary coordination to improve liver cancer outcomes.
Source: Annals of Hepatology
Institution: Institute of Cardiology
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W7204243155
